Juno Therapeutics Breaking News Baylor Receives $3.5M From NHGRI to Study Newborn Genetic Telehealth Services in Texas Investigators Urge Additional Screening to Catch Maternal Cancer From Nonreportable NIPT Results GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients BeiGene, CLL Society Partner to Promote Biomarker Testing in CLL, SLL Abselion Closes £6.6M Series A Round
